Literature DB >> 17638079

Peritoneovenous shunt after failure of octreotide treatment for chylous ascites in lymphangioleiomyomatosis.

Laurent Lefrou1, Louis d'Alteroche, Yahia Harchaoui, Dominique Franco, Etienne Henry Metman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17638079     DOI： 10.1007/s10620-006-9353-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

1.  Octreotide for therapy of chylous ascites in yellow nail syndrome.

Authors:  A Widjaja; K F Gratz; J Ockenga; S Wagner; M P Manns
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

2.  Chylous ascites following radical nephrectomy: efficiency of octreotide as treatment of a ruptured thoracic duct.

Authors:  M Ferrandière; E Hazouard; V Guicheteau; A Gouchet; M Bensenouci; C Lamotte; C Mercier
Journal:  Intensive Care Med       Date:  2000-04       Impact factor: 17.440

3.  Lymphangioleiomyomatosis. Clinical course in 32 patients.

Authors:  J R Taylor; J Ryu; T V Colby; T A Raffin
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

4.  Rapid resolution of chylous ascites after liver transplantation using somatostatin analog and total parenteral nutrition.

Authors:  A M Shapiro; V G Bain; D L Sigalet; N M Kneteman
Journal:  Transplantation       Date:  1996-05-15       Impact factor: 4.939

Review 5.  Lymphangioleiomyomatosis, chylous ascites, and diet.

Authors:  E Calvo; L Amarillas; M A Mateos; J L Orradre; G Gilsanz; J L Alvarez-Sala; D Espinos
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

6.  Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

Authors:  T Urban; R Lazor; J Lacronique; M Murris; S Labrune; D Valeyre; J F Cordier
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

Review 7.  Chylous ascites: diagnosis, causes and treatment.

Authors:  P F Laterre; T Dugernier; M S Reynaert
Journal:  Acta Gastroenterol Belg       Date:  2000 Jul-Sep       Impact factor: 1.316

8.  [Lymphangiomyomatosis with chylous ascites treatment successfully by peritoneo-venous shunting].

Authors:  M Kimura; T Morikawa; K Takeuchi; H Furuie; M Fukimura; R Mikami; Y Kakuta; S Kawamura; Y Tashiro
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1996-05

9.  Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue.

Authors:  J C Reubi; U Horisberger; B Waser; J O Gebbers; J Laissue
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

10.  [Chylaskos in lymphangioleiomyomatosis. Peritoneo-venous drainage with Denver shunt].

Authors:  H Dienemann; J Witte; L Szabo
Journal:  Dtsch Med Wochenschr       Date:  1985-06-07       Impact factor: 0.628
View more
  2 in total

1.  Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer Patients.

Authors:  Hooman Yarmohammadi; Lynn A Brody; Joseph P Erinjeri; Anne M Covey; F Edward Boas; Etay Ziv; Majid Maybody; Adrian J Gonzalez-Aguirre; Karen T Brown; Joel Sheinfeld; George I Getrajdman
Journal:  J Vasc Interv Radiol       Date:  2016-03-07       Impact factor: 3.464

2.  Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.

Authors:  Masashi Namba; Takeshi Masuda; Takashi Nakamura; Yasushi Horimasu; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.